Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30225% above fair value
$6.57+0.77 (+13.28%)
Close on Nov 18, 2026Market cap $98.44MP/E –Yield –
Cumberland Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cumberland Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was $683.90K, down 90.3% year over year. For fiscal 2025 it was $4.83M. Over ten years it grew -1.7% a year on average. The highest annual figure on record is $8.46M in fiscal 2011.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.83M | – |
| FY2024 | Dec 31, 2024 | -$678.65K | -111.7% |
| FY2023 | Dec 31, 2023 | $5.81M | -30.4% |
| FY2022 | Dec 31, 2022 | $8.35M | +33.9% |
| FY2021 | Dec 31, 2021 | $6.24M | +18.3% |
| FY2020 | Dec 31, 2020 | $5.27M | +87.7% |
| FY2019 | Dec 31, 2019 | $2.81M | +5.8% |
| FY2018 | Dec 31, 2018 | $2.66M | – |
| FY2017 | Dec 31, 2017 | -$833.67K | -290.1% |
| FY2016 | Dec 31, 2016 | $438.61K | -92.4% |
| FY2015 | Dec 31, 2015 | $5.73M | -12.2% |
| FY2014 | Dec 31, 2014 | $6.53M | +906.6% |
| FY2013 | Dec 31, 2013 | $648.71K | -90.3% |
| FY2012 | Dec 31, 2012 | $6.67M | -21.2% |
| FY2011 | Dec 31, 2011 | $8.46M | – |
| FY2010 | Dec 31, 2010 | -$230.50K | – |
| FY2009 | Dec 31, 2009 | -$196.83K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $130.46K | -84.0% |
| Q1 FY2026 | Mar 31, 2026 | $387.03K | -89.9% |
| Q4 FY2025 | Dec 31, 2025 | $3.03K | -99.8% |
| Q3 FY2025 | Sep 30, 2025 | $163.39K | -64.5% |
| Q2 FY2025 | Jun 30, 2025 | $817.32K | – |
| Q1 FY2025 | Mar 31, 2025 | $3.85M | – |
| Q4 FY2024 | Dec 31, 2024 | $1.90M | +91.9% |
| Q3 FY2024 | Sep 30, 2024 | $460.12K | -61.1% |
| Q2 FY2024 | Jun 30, 2024 | -$862.84K | -116.7% |
| Q1 FY2024 | Mar 31, 2024 | -$2.18M | – |
| Q4 FY2023 | Dec 31, 2023 | $991.45K | -73.9% |
| Q3 FY2023 | Sep 30, 2023 | $1.18M | -53.5% |
| Q2 FY2023 | Jun 30, 2023 | $5.16M | +135.4% |
| Q1 FY2023 | Mar 31, 2023 | -$1.53M | – |
| Q4 FY2022 | Dec 31, 2022 | $3.79M | +94.4% |
| Q3 FY2022 | Sep 30, 2022 | $2.54M | – |
| Q2 FY2022 | Jun 30, 2022 | $2.19M | -18.3% |
| Q1 FY2022 | Mar 31, 2022 | -$177.48K | -110.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.95M | +141.3% |
| Q3 FY2021 | Sep 30, 2021 | -$161.96K | -119.9% |
| Q2 FY2021 | Jun 30, 2021 | $2.68M | -3.7% |
| Q1 FY2021 | Mar 31, 2021 | $1.77M | +104.0% |
| Q4 FY2020 | Dec 31, 2020 | $808.29K | +4.0% |
| Q3 FY2020 | Sep 30, 2020 | $812.76K | +23.7% |
| Q2 FY2020 | Jun 30, 2020 | $2.79M | +55.8% |
| Q1 FY2020 | Mar 31, 2020 | $865.81K | – |
| Q4 FY2019 | Dec 31, 2019 | $777.21K | -77.4% |
| Q3 FY2019 | Sep 30, 2019 | $657.09K | – |
| Q2 FY2019 | Jun 30, 2019 | $1.79M | +136.2% |
| Q1 FY2019 | Mar 31, 2019 | -$413.21K | -393.7% |
| Q4 FY2018 | Dec 31, 2018 | $3.44M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.68M | -274.5% |
| Q2 FY2018 | Jun 30, 2018 | $757.28K | – |
| Q1 FY2018 | Mar 31, 2018 | $140.71K | -89.3% |
| Q4 FY2017 | Dec 31, 2017 | -$562.62K | -171.5% |
| Q3 FY2017 | Sep 30, 2017 | $963.09K | +262.3% |
| Q2 FY2017 | Jun 30, 2017 | -$2.55M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.32M | – |
| Q4 FY2016 | Dec 31, 2016 | $787.20K | – |
| Q3 FY2016 | Sep 30, 2016 | $265.80K | – |
See a number that looks wrong?